OrbiMed’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $134M | Buy |
|
|||||
|
2025
Q1 | $111M | Buy |
|
|||||
|
2024
Q4 | $84.8M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $48.6M | Sell |
|
|||||
|
2023
Q1 | $52.1M | Sell |
|
|||||
|
2022
Q4 | $64.2M | Sell |
|
|||||
|
2022
Q3 | $79.8K | Sell |
|
|||||
|
2022
Q2 | $96.2K | Sell |
|
|||||
|
2022
Q1 | $124M | Sell |
|
|||||
|
2021
Q4 | $139M | Sell |
|
|||||
|
2021
Q3 | $128M | Hold |
|
|||||
|
2021
Q2 | $117M | Hold |
|
|||||
|
2021
Q1 | $94.2M | Buy |
|
|||||
|
2020
Q4 | $93.6M | Buy |
|
|||||
|
2020
Q3 | $56.4M | Buy |
|
|||||
|
2020
Q2 | $36.7M | Hold |
|
|||||
|
2020
Q1 | $33.3M | Sell |
|
|||||
|
2019
Q4 | $101M | Sell |
|
|||||
|
2019
Q3 | $112M | Sell |
|
|||||
|
2019
Q2 | $132M | Hold |
|
|||||
|
2019
Q1 | $137M | Buy |
|
|||||
|
2018
Q4 | $71.3M | Sell |
|
|||||
|
2018
Q3 | $172M | Buy |
|
|||||
|
2018
Q2 | $127M | Sell |
|
|||||
|
2018
Q1 | $143M | Sell |
|
|||||
|
2017
Q4 | $127M | Sell |
|
|||||
|
2017
Q3 | $152M | Sell |
|
|||||
|
2017
Q2 | $217M | Hold |
|
|||||
|
2017
Q1 | $173M | Buy |
|
|||||
|
2016
Q4 | $127M | Sell |
|
|||||
|
2016
Q3 | $166M | Buy |
|
|||||
|
2016
Q2 | $51M | Buy |
|
|||||
|
2016
Q1 | $10.1M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $3.48M | Hold |
|
|||||
|
2013
Q2 | $3.36M | Buy |
|